{"version":"1.0","provider_name":"Myriad Urology","provider_url":"https:\/\/myriad.com\/urology","author_name":"ssotelo","author_url":"https:\/\/myriad.com\/urology\/blog\/author\/ssotelo\/","title":"Applying Prolaris Data to an Evidentiary Framework | Myriad Urology","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"o1eqK3eQRA\"><a href=\"https:\/\/myriad.com\/urology\/blog\/applying-prolaris-data-to-an-evidentiary-framework\/\">Applying Prolaris Data to an Evidentiary Framework<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/myriad.com\/urology\/blog\/applying-prolaris-data-to-an-evidentiary-framework\/embed\/#?secret=o1eqK3eQRA\" width=\"600\" height=\"338\" title=\"&#8220;Applying Prolaris Data to an Evidentiary Framework&#8221; &#8212; Myriad Urology\" data-secret=\"o1eqK3eQRA\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/myriad.com\/urology\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Learn more about how the Prolaris\u00ae prostate cancer (PCa) prognostic test aligns with the widely cited and accepted Simon et al. evidentiary framework of 2009, positioning it for favorable payer coverage decisions. Analysis across six published studies with non-overlapping patient cohorts showing notably consistent and significant results places Prolaris firmly within LOE II \u2013 which &hellip;","thumbnail_url":"https:\/\/myriad.com\/urology\/wp-content\/uploads\/sites\/12\/2023\/11\/Myriad.com_.jpg","thumbnail_width":622,"thumbnail_height":438}